Insider Transactions in Q2 2024 at 10x Genomics, Inc. (TXG)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 11
2024
|
Sridhar Kosaraju |
BUY
Grant, award, or other acquisition
|
Direct |
8,649
+17.39%
|
-
|
|
Jun 11
2024
|
John R Stuelpnagel |
BUY
Grant, award, or other acquisition
|
Direct |
8,649
+2.45%
|
-
|
|
Jun 11
2024
|
Mathai Mammen |
BUY
Grant, award, or other acquisition
|
Direct |
8,649
+4.58%
|
-
|
|
Jun 11
2024
|
Shehnaaz Suliman |
BUY
Grant, award, or other acquisition
|
Direct |
8,649
+39.48%
|
-
|
|
Jun 11
2024
|
Kimberly J Popovits |
BUY
Grant, award, or other acquisition
|
Direct |
8,649
+39.48%
|
-
|
|
May 29
2024
|
Serge Saxonov Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
425
-0.05%
|
-
|
|
May 22
2024
|
Benjamin J. Hindson |
SELL
Open market or private sale
|
Direct |
4,087
-1.15%
|
$98,088
$24.3 P/Share
|
|
May 22
2024
|
Serge Saxonov Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,877
-0.55%
|
$117,048
$24.3 P/Share
|
|
May 22
2024
|
Justin J. Mc Anear |
SELL
Open market or private sale
|
Direct |
2,936
-1.97%
|
$70,464
$24.3 P/Share
|